Gemcitabine Plus S-1 as First-line Chemotherapy in Chinese Patients With Advanced Pancreatic Cancer: A Prospective Study

被引：0
|
作者：
Wu, W. [1 ]
Zheng, Y. [1 ]
Jiang, W. [1 ]
Liu, L. [1 ]
Tong, Z. [1 ]
Zhang, H. [1 ]
Fang, W. [1 ]
Zhao, P. [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
PANCREAS | 2019年 / 48卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1548 / 1548
页数：1
相关论文
共 50 条
  • [41] Randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin for first-line treatment of advanced gastric cancer
    Higuchi, Katsuhiko
    Koizumi, Wasaburo
    Yamada, Yasuhide
    Nishikawa, Kazuhiro
    Gotoh, Masahiro
    Fuse, Nozomu
    Sugimoto, Naotoshi
    Nishina, Tomohiro
    Amagai, Kenji
    Chin, Keisho
    Niwa, Yasumasa
    Negoro, Yuji
    Imamura, Hiroshi
    Tsuda, Masahiro
    Yasui, Hirotumi
    Fujii, Hirofumi
    Yamaguchi, Kensei
    Yasui, Hisateru
    Hamada, Chikuma
    Hyodo, Ichinosuke
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [42] Retrospective Study of Gemcitabine plus S-1 versus Gemcitabine Alone in Cases with Unresectable Advanced Pancreatic Cancer
    Suzuki, Shuji
    Ozaki, Yuhi
    Saida, Shin
    Kaji, Satoshi
    Koike, Nobusada
    Harada, Nobuhiko
    Hayashi, Tsuneo
    Suzuki, Mamoru
    HEPATO-GASTROENTEROLOGY, 2013, 60 (124) : 916 - 920
  • [43] Efficacy and safety of nab-paclitaxel plus s-1 in the first-line treatment of advanced pancreatic cancer.
    Zhang, Wen
    Du, Chun-Xia
    Sun, Yongkun
    Yang, Lin
    Cui, Chengxu
    Jiang, Zhichao
    Wang, Jinwan
    Zhou, Ai-Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Clinical observation of nab-paclitaxel plus S-1 as first-line chemotherapy for advanced gastric cancer.
    Hu, Yi
    Sun, Danyang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Pilot study of simplified low-dose S-1 plus CPT-11 as first-line chemotherapy for patients with advanced colorectal cancer
    Yoshimatsu, Kazuhiko
    Yokomizo, Hajime
    Fujimoto, Takashi
    Umehara, Arihiro
    Otani, Taisuke
    Matsumoto, Atsuo
    Osawa, Gakuji
    Ogawa, Kenji
    ANTICANCER RESEARCH, 2007, 27 (3B) : 1657 - 1661
  • [46] A phase II study of biweekly oxaliplatin plus S-1 combination chemotherapy as a first-line treatment for patients with metastatic or advanced gastric cancer in China
    Xiao, Cheng
    Qian, Jiong
    Zheng, Yulong
    Song, Fang
    Wang, Qiangfeng
    Jiang, Haiping
    Mao, Chenyu
    Xu, Nong
    MEDICINE, 2019, 98 (20)
  • [47] A phase III study of TAS-118 plus oxaliplatin versus S-1 plus cisplatin as first-line chemotherapy in patients with advanced gastric cancer (SOLAR study)
    Kang, Y.
    Chin, K.
    Chung, H.
    Kadowaki, S.
    Oh, S.
    Nakayama, N.
    Lee, K.
    Hara, H.
    Chung, I.
    Tsuda, M.
    Park, S.
    Hosaka, H.
    Hironaka, S.
    Miyata, Y.
    Ryu, M.
    Takeuchi, M.
    Baba, H.
    Hyodo, I.
    Bang, Y.
    Boku, N.
    ANNALS OF ONCOLOGY, 2019, 30
  • [48] Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study
    Zhou, Jing
    Zhao, Rongce
    Wen, Feng
    Zhang, Pengfei
    Tang, Ruilei
    Du, Zedong
    He, Xiaofeng
    Zhang, Jian
    Li, Qiu
    MEDICAL ONCOLOGY, 2015, 32 (04)
  • [49] Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study
    Jing Zhou
    Rongce Zhao
    Feng Wen
    Pengfei Zhang
    Ruilei Tang
    Zedong Du
    Xiaofeng He
    Jian Zhang
    Qiu Li
    Medical Oncology, 2015, 32
  • [50] Feasibility Study of S-1 plus Weekly Docetaxel Combined with Concurrent Radiotherapy in Advanced Gastric Cancer Refractory to First-line Chemotherapy
    Fujitani, Kazumasa
    Tsujinaka, Toshimasa
    Yamasaki, Hideya
    Hirao, Motohiro
    Yoshida, Ken
    Kurokawa, Yukinori
    ANTICANCER RESEARCH, 2009, 29 (08) : 3385 - 3391
12345